Human Rabies Immunoglobulin Dose
The recommended dose of human rabies immunoglobulin (HRIG) is 20 IU/kg body weight, applicable to all age groups including children. 1, 2
Dosing Specifications
The standard dose is:
- 20 IU/kg body weight (equivalent to 0.133 mL/kg when using standard formulations) 1
- This formula is universal across all ages—adults, children, and infants 3
Critical Administration Guidelines
Anatomical Infiltration
If anatomically feasible, infiltrate the full calculated dose thoroughly around and into the wound(s). 1 Any remaining volume after wound infiltration should be administered intramuscularly at a site distant from vaccine administration 3.
This recommendation stems from documented failures of postexposure prophylaxis when smaller amounts of HRIG were infiltrated at exposure sites 3, 1. The evidence clearly shows that inadequate local infiltration has been associated with treatment failures abroad 3.
Timing Window
- Administer at the beginning of antirabies prophylaxis (day 0) 1
- If not given initially, HRIG can still be administered up to and including day 7 after the first vaccine dose 1
- Beyond day 7, HRIG is contraindicated as antibody response to vaccine is presumed to have occurred 3
Important Caveats
Do Not Exceed Recommended Dose
Never administer more than 20 IU/kg. 3 Exceeding this dose can partially suppress active antibody production from the vaccine, potentially compromising protection 1.
Anatomical Site Restrictions
- Never administer HRIG in the same syringe or same anatomical site as the vaccine 3
- Avoid the gluteal region for injection due to sciatic nerve injury risk 2
- Subsequent vaccine doses in the series can be given in the same location where HRIG was administered 1
Previously Vaccinated Patients
HRIG should not be administered to persons with documented history of:
- Complete preexposure or postexposure vaccination with cell culture vaccine 1
- Previous vaccination with documented rabies antibody titer 3
These patients receive vaccine only 1.
Clinical Evidence Supporting This Dose
The 20 IU/kg dose was established through controlled studies demonstrating that this regimen:
- Produces detectable passive rabies antibody levels in all recipients within 24 hours 2, 4
- Provides immediate protection until active antibody production begins 1
- Does not interfere with endogenous antibody response to vaccine when given at this dose 2, 4
- Has maintained nearly 100% efficacy in preventing rabies when combined with vaccine 3
Recent studies confirm excellent safety profiles with this dosing strategy, showing only mild local reactions in most cases 5, 6. A 2020 study demonstrated 91% adherence to this dosing guideline with 98% of patients receiving doses within 10% of the 20 IU/kg target 7.